ESSA Pharma Inc (NASDAQ:EPIX)
| 2.97 Delayed Data As of Mar 22 |  -0.08 / -2.62%Today’s Change | 1.40 Today|||52-Week Range 8.03 | +17.86% Year-to-Date |
Latest EPIX News | Press Releases
No recent news for ESSA Pharma Inc.
Today’s Trading
| Previous close | 3.05 |
| Today’s open | 2.99 |
| Day’s range | 2.78 - 3.01 |
| Volume | 2,436 |
| Average volume (3 months) | 261,045 |
| Market cap | $135.4M |
Data as of 3:59pm ET, 03/22/2023
Growth & Valuation
| Earnings growth (last year) | +16.66% |
| Earnings growth (this year) | -0.75% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.81 |
Competitors
| ---- | ||
| YMABY-mAbs Therapeutics ... | -0.17 | -5.69% |
| AKBAAkebia Therapeutics ... | -0.04 | -5.86% |
| PRPHProphase Labs Inc | +0.14 | +1.80% |
Data as of 3:59pm ET, 03/22/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$35.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
